Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevention of Stroke and Dementia in Primary Care (INVADE)

This study has been terminated.
Sponsor:
Collaborators:
Allgemeine Ortskrankenkasse Bayern (AOK)
Stiftung Deutsche Schlaganfall-Hilfe
Ratiopharm GmbH
Sanofi-Synthelabo
Organon
Teva Pharma GmbH
Bayer
Berlin-Chemie Menarini
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT01107548
First received: April 19, 2010
Last updated: February 16, 2012
Last verified: April 2010

April 19, 2010
February 16, 2012
January 2001
December 2008   (final data collection date for primary outcome measure)
  • Incidence of long-term care disability [ Time Frame: 8 years ] [ Designated as safety issue: No ]
  • Incidence of stroke [ Time Frame: 8 Years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01107548 on ClinicalTrials.gov Archive Site
Reduction of cardiovascular risk factors [ Time Frame: 8 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Prevention of Stroke and Dementia in Primary Care
Intervention Project of Cerebrovascular Diseases and Dementia in the District of Ebersberg

In Western Countries, stroke and dementia are the main causes of long-term disability, dependency, and nursing home admission. Due to demographic trends a continuous increase of patient numbers can be expected.

There is growing evidence that vascular risk factors which are implicated in the etiology of stroke also play important etiologic roles in both vascular dementia and Alzheimer disease. The present project is aimed at the reduction of stroke and dementia by means of a systematic detection and subsequent treatment of vascular risk factors by the family doctor based on established guidelines.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Stroke
  • Dementia
  • Disability
Other: Systematic detection of vascular risk factors and subsequent evidence-based treatment
Experimental: Evidence-based treatment, lifestyle counseling
Intervention: Other: Systematic detection of vascular risk factors and subsequent evidence-based treatment

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
3908
March 2010
December 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 55 years or over
  • Member of a particular health insurance plan (AOK)
  • Resident of the district of Ebersberg

Exclusion Criteria:

  • None
Both
55 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01107548
080250hb
No
Horst Bickel, Dept. of Psychiatry, Technical University of munich
Technische Universität München
  • Allgemeine Ortskrankenkasse Bayern (AOK)
  • Stiftung Deutsche Schlaganfall-Hilfe
  • Ratiopharm GmbH
  • Sanofi-Synthelabo
  • Organon
  • Teva Pharma GmbH
  • Bayer
  • Berlin-Chemie Menarini
Principal Investigator: Horst Bickel, PhD Dept. of Psychiatry, Technical University of Munich
Technische Universität München
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP